A phase 1 dynamic accelerated titration dose escalation study of the vascular disrupting agent NPI-2358

被引:0
|
作者
Spear, M. A.
LoRusso, P.
Tolcher, A. W.
Lin, C.
Wang, D.
Heath, E.
Lloyd, G. K.
Cropp, G.
Papadopoulos, K. P.
机构
[1] Nereus Pharmaceut, San Diego, CA USA
[2] Karmanos Canc Ctr, Detroit, MI USA
[3] Inst Drug Dev, San Antonio, TX USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
14097
引用
收藏
页数:1
相关论文
共 50 条
  • [21] A Phase 1 Dose Escalation Study of Accelerated Partial Breast Irradiation: A 32 Gy Threshold
    Braunstein, L. Z.
    Salama, L. W.
    MacDonald, S.
    Powell, S. N.
    Recht, A.
    Taghian, A. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S57 - S57
  • [22] Results from phase 1 dose escalation study of the proteasome inhibitor NPI-0052 in patients with solid tumors and lymphomas
    Kurzrock, Razelle
    Hamlin, Paul
    Younes, Anas
    Hong, David
    Gordon, Michael
    Hannah, Alison
    Palladino, Michael A.
    Lloyd, G. Kenneth
    Longenecker, Angie M.
    Neuteboom, Saskia T. C.
    Cropp, Gillian F.
    Spears, Matthew A.
    Aghajanian, Carol
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3433S - 3433S
  • [23] A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer
    Hyehyun Jeong
    Yong Sang Hong
    Jeong Eun Kim
    Hyeong-Seok Lim
    Joong Bae Ahn
    Sang Joon Shin
    Young Suk Park
    Seung Tae Kim
    Sae-Won Han
    Tae-You Kim
    Tae Won Kim
    Investigational New Drugs, 2021, 39 : 1335 - 1347
  • [24] A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer
    Jeong, Hyehyun
    Hong, Yong Sang
    Kim, Jeong Eun
    Lim, Hyeong-Seok
    Ahn, Joong Bae
    Shin, Sang Joon
    Park, Young Suk
    Kim, Seung Tae
    Han, Sae-Won
    Kim, Tae-You
    Kim, Tae Won
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (05) : 1335 - 1347
  • [25] Dose-response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin
    Lorza, Andres M. Arias
    Ravi, Harshan
    Philip, Rohit C.
    Galons, Jean-Philippe
    Trouard, Theodore P.
    Parra, Nestor A.
    Von Hoff, Daniel D.
    Read, William L.
    Tibes, Raoul
    Korn, Ronald L.
    Raghunand, Natarajan
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [26] Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer
    Kelsey, Chris R.
    Das, Shiva
    Gu, Lin
    Dunphy, Frank R., III
    Ready, Neal E.
    Marks, Lawrence B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (05): : 997 - 1004
  • [27] Phase 1 Dose-Escalation Study of Accelerated Fractionation and Concurrent Chemotherapy for Locally Advanced Lung Cancer
    Kelsey, C. R.
    Yoo, D. S.
    Das, S. K.
    Dunphy, F.
    Ready, N.
    Crawford, J.
    Marks, L. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S87 - S87
  • [28] Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors
    Shiah, Her-Shyong
    Chiang, Nai-Jung
    Lin, Chia-Chi
    Yen, Chia-Jui
    Tsai, Hui-Jen
    Wu, Shang-Yin
    Su, Wu-Chou
    Chang, Kwang-Yu
    Wang, Ching-Chiung
    Chang, Jang-Yang
    Chen, Li-Tzong
    ONCOLOGIST, 2021, 26 (04): : E567 - E579
  • [29] A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy.
    Chiang, Nai-Jung
    Shiah, Her-Shyong
    Lin, Chia-Chi
    Yen, Chia-Jui
    Tsai, Hui-Jen
    Wu, Shang-Yin
    Su, Wu-Chou
    Chang, Kwang-Yu
    Chen, Li-Tzong
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] A PHASE I DOSE-ESCALATION STUDY (ISIDE-BT-1) OF ACCELERATED IMRT WITH TEMOZOLOMIDE IN PATIENTS WITH GLIOBLASTOMA
    Morganti, Alessio G.
    Balducci, Mario
    Salvati, Maurizio
    Esposito, Vincenzo
    Romanelli, Pantaleo
    Ferro, Marica
    Calista, Franco
    Digesu, Cinzia
    Macchia, Gabriella
    Ianiri, Massimo
    Deodato, Francesco
    Cilla, Savino
    Piermattei, Angelo
    Valentini, Vincenzo
    Cellini, Numa
    Cantore, Gian Paolo
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01): : 92 - 97